• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绵羊对刚地弓形虫S48株初次和再次感染的局部及全身抗体反应动力学

Kinetics of the local and systemic antibody response to primary and secondary infection with S48 Toxoplasma gondii in sheep.

作者信息

Wastling J M, Harkins D, Maley S, Innes E, Panton W, Thomson K, Buxton D

机构信息

Moredun Research Institute, Edinburgh, UK.

出版信息

J Comp Pathol. 1995 Jan;112(1):53-62. doi: 10.1016/s0021-9975(05)80089-1.

DOI:10.1016/s0021-9975(05)80089-1
PMID:7722008
Abstract

Vaccination of sheep with live tachyzoites of Toxoplasma gondii, strain S48, affords protection against subsequent challenge with the parasite, but the mechanisms of immunity have not been fully determined. To understand better the nature of the antibody response the kinetics of both local and systemic antibody production were monitored in vaccinated sheep by means of an enzyme-linked immunosorbent assay and Western blotting. Local specific IgG production was analysed in efferent lymph obtained from the cannulated pre-femoral lymph node draining the site of infection. Antibody in efferent lymph plasma and peripheral blood serum from animals vaccinated with S48 tachyzoites was monitored and compared with IgG production in vaccinated sheep given a secondary tachyzoite challenge. Secondary challenge resulted in a clear immunological memory response, antibody being detected in the lymph 3 to 4 days after infection as compared with 7 to 8 days after a primary infection. IgG production was dominated by antibody recognizing a protein with an apparent molecular weight of 30 kDa, but other antigens (32, 24 and 11 kDa) were also readily detected.

摘要

用刚地弓形虫S48株的活速殖子对绵羊进行疫苗接种,可使其免受该寄生虫随后的攻击,但免疫机制尚未完全明确。为了更好地了解抗体反应的本质,通过酶联免疫吸附测定和蛋白质印迹法监测了接种疫苗的绵羊局部和全身抗体产生的动力学。在从引流感染部位的插管股前淋巴结获得的输出淋巴中分析局部特异性IgG的产生。监测接种S48速殖子的动物输出淋巴血浆和外周血血清中的抗体,并与再次接受速殖子攻击的接种绵羊的IgG产生情况进行比较。再次攻击导致明显的免疫记忆反应,感染后3至4天在淋巴中检测到抗体,而初次感染后为7至8天。IgG的产生主要由识别表观分子量为30 kDa的蛋白质的抗体主导,但其他抗原(32、24和11 kDa)也很容易被检测到。

相似文献

1
Kinetics of the local and systemic antibody response to primary and secondary infection with S48 Toxoplasma gondii in sheep.绵羊对刚地弓形虫S48株初次和再次感染的局部及全身抗体反应动力学
J Comp Pathol. 1995 Jan;112(1):53-62. doi: 10.1016/s0021-9975(05)80089-1.
2
Western blot analysis of the IgG response of sheep vaccinated with S48 Toxoplasma gondii (Toxovax).用刚地弓形虫S48株(Toxovax)免疫的绵羊IgG反应的蛋白质印迹分析。
Res Vet Sci. 1994 Nov;57(3):384-6. doi: 10.1016/0034-5288(94)90135-x.
3
Kinetics of interferon gamma production in vivo during infection with the S48 vaccine strain of Toxoplasma gondii.感染刚地弓形虫S48疫苗株期间体内γ干扰素产生的动力学
J Comp Pathol. 1995 Jul;113(1):89-94. doi: 10.1016/s0021-9975(05)80074-x.
4
Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine.用活的(S48)刚地弓形虫疫苗对绵羊进行疫苗接种18个月后的实验性攻毒。
Vet Rec. 1993 Sep 25;133(13):310-2. doi: 10.1136/vr.133.13.310.
5
Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1.通过接种SAG2和SRS1对刚地弓形虫致死性感染和脑囊肿形成的改良保护作用。
J Vet Med Sci. 2001 Apr;63(4):433-8. doi: 10.1292/jvms.63.433.
6
Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.用包裹在聚乳酸-羟基乙酸共聚物(PLG)微球中的刚地弓形虫速殖子抗原进行鼻内免疫可诱导绵羊产生体液免疫和细胞介导免疫。
Vaccine. 2004 Sep 28;22(29-30):3929-41. doi: 10.1016/j.vaccine.2004.04.022.
7
Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii.用刚地弓形虫粗制棒状体蛋白对猪进行疫苗接种可部分预防组织囊肿的形成。
Vet Parasitol. 2005 May 15;129(3-4):209-17. doi: 10.1016/j.vetpar.2005.01.006.
8
Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant.用活的弓形虫不完全株(S48)对绵羊进行疫苗接种及其在怀孕时对攻击的免疫力。
Vet Rec. 1991 Aug 3;129(5):89-93. doi: 10.1136/vr.129.5.89.
9
Primary and secondary responses of the ovine lymph node to Toxoplasma gondii: cell output in efferent lymph and parasite detection.绵羊淋巴结对刚地弓形虫的初次和二次反应:输出淋巴中的细胞输出及寄生虫检测
J Comp Pathol. 1994 Oct;111(3):231-41. doi: 10.1016/s0021-9975(05)80002-7.
10
Enzyme-linked immunosorbent assays for the measurement of specific antibodies in experimentally induced ovine toxoplasmosis.用于测量实验性诱导绵羊弓形虫病中特异性抗体的酶联免疫吸附测定。
Epidemiol Infect. 1988 Apr;100(2):205-12. doi: 10.1017/s0950268800067339.

引用本文的文献

1
The combination of RPA-CRISPR/Cas12a and Leptospira IgM RDT enhances the early detection of leptospirosis.RPA-CRISPR/Cas12a 与钩端螺旋体 IgM RDT 的联合应用提高了钩端螺旋体病的早期检出率。
PLoS Negl Trop Dis. 2023 Aug 25;17(8):e0011596. doi: 10.1371/journal.pntd.0011596. eCollection 2023 Aug.
2
Key Limitations and New Insights Into the Parasite Stage Switching for Future Vaccine Development in Human, Livestock, and Cats.人类、家畜和猫的寄生虫阶段转换的主要局限性和新见解,以用于未来疫苗的开发。
Front Cell Infect Microbiol. 2020 Nov 25;10:607198. doi: 10.3389/fcimb.2020.607198. eCollection 2020.
3
Congenital Transmission of After Experimental Reinfection With Brazilian Typical Strains in Chronically Infected Sheep.
慢性感染绵羊经巴西典型菌株实验性再感染后的先天性传播
Front Vet Sci. 2019 Apr 2;6:93. doi: 10.3389/fvets.2019.00093. eCollection 2019.
4
Increased Toxoplasma gondii positivity relative to age in 125 Scottish sheep flocks; evidence of frequent acquired infection.125 个苏格兰绵羊群中,弓形虫阳性率随年龄增长而增加;表明频繁发生后天感染。
Vet Res. 2011 Dec 21;42(1):121. doi: 10.1186/1297-9716-42-121.
5
Immunodiagnosis of primary Toxoplasma gondii infection in sheep by the use of a P30 IgG avidity ELISA.使用P30 IgG亲和力ELISA对绵羊原发性弓形虫感染进行免疫诊断。
Parasitol Res. 2003 Sep;91(2):171-4. doi: 10.1007/s00436-003-0964-9. Epub 2003 Aug 16.
6
Expression of herpes simplex virus thymidine kinase in Toxoplasma gondii attenuates tachyzoite virulence in mice.单纯疱疹病毒胸苷激酶在刚地弓形虫中的表达减弱了速殖子在小鼠中的毒力。
Infect Immun. 1999 Oct;67(10):5292-7. doi: 10.1128/IAI.67.10.5292-5297.1999.